Abstract
The extent to which beta-adrenoceptor blocking drugs counteract the biochemical responses to an infusion of terbutaline, a beta 2-adrenoceptor agonist, has been investigated. In this study the beta 1-selectivity of metoprolol was compared with the non-selective beta-adrenoceptor blocker propranolol. The hypokalaemia produced by an infusion of terbutaline was reduced by low dose (50 mg) and high dose (200 mg) metoprolol and by low dose (40 mg) and high dose (160 mg) propranolol. The effects of propranolol on terbutaline induced hypokalaemia were more marked than those of metoprolol at both low dose (P = 0.01) and high dose (P = 0.05). Furthermore low dose metoprolol had less effect than high dose metoprolol (P = 0.05). The serum potassium appeared to rise slightly after propranolol. Low and high doses of both beta-adrenoceptor blockers markedly reduced the terbutaline-induced hyperglycaemia, but the differences between the two drugs were not statistically significant.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kendall M. J. Are selective beta-adrenoceptor blocking drugs an advantage? J R Coll Physicians Lond. 1981 Jan;15(1):33–40. [PMC free article] [PubMed] [Google Scholar]
- Kendall M. J., Dean S., Bradley D., Gibson R., Worthington D. J. Cardiovascular and metabolic effects of terbutaline. J Clin Hosp Pharm. 1982 Mar;7(1):31–36. doi: 10.1111/j.1365-2710.1982.tb00905.x. [DOI] [PubMed] [Google Scholar]
- Lager I., Blohmé G., Smith U. Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics. Lancet. 1979 Mar 3;1(8114):458–462. doi: 10.1016/s0140-6736(79)90821-3. [DOI] [PubMed] [Google Scholar]
- Leitch A. G., Clancy L. J., Costello J. F., Flenley D. C. Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. Br Med J. 1976 Feb 14;1(6006):365–367. doi: 10.1136/bmj.1.6006.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lockwood R. H., Lum B. K. Effects of adrenergic agonists and antagonists on potassium metabolism. J Pharmacol Exp Ther. 1974 Apr;189(1):119–129. [PubMed] [Google Scholar]
- Loubatières A., Mariani M. M., Sorel G., Savi L. The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor. Diabetologia. 1971 Jun;7(3):127–132. doi: 10.1007/BF01212541. [DOI] [PubMed] [Google Scholar]
- Marlin G. E., Turner P. Intravenous treatment with rimiterol and salbutamol in asthma. Br Med J. 1975 Jun 28;2(5973):715–719. doi: 10.1136/bmj.2.5973.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petch M. C., McKay R., Bethune D. W. The effect of beta, adrenergic blockade on serum potassium and glucose levels during open heart surgery. Eur Heart J. 1981 Apr;2(2):123–126. doi: 10.1093/oxfordjournals.eurheartj.a061171. [DOI] [PubMed] [Google Scholar]
- Phillips P. J., Vedig A. E., Jones P. L., Chapman M. G., Collins M., Edwards J. B., Smeaton T. C., Duncan B. M. Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol. Br J Clin Pharmacol. 1980 May;9(5):483–491. doi: 10.1111/j.1365-2125.1980.tb05844.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- William-Olsson T., Fellenius E., Björntorp P., Smith U. Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration. Acta Med Scand. 1979;205(3):201–206. doi: 10.1111/j.0954-6820.1979.tb06031.x. [DOI] [PubMed] [Google Scholar]
- Woods K. L., Linton S. P., Kendall M. J., Faragher E. B., Grieve R. J. Exercise responses of healthy subjects in the evaluation of cardioselectivity of beta-blockers. Eur J Clin Pharmacol. 1979 May 21;15(4):229–233. doi: 10.1007/BF00618510. [DOI] [PubMed] [Google Scholar]